aileen-yan@lordmed.comhttps://weixin.qq.com/
AI MedTech Startup AIMED Secures Tens of Millions in Financing, HONSUN Accelerates Commercialization of Remote Cardiopulmonary Auscultation
2026-03-24 17:09
March 24, 2026 – Huzhou AIMED Artificial Intelligence Technology Co., Ltd. held a grand angel round financing signing ceremony at the Zhejiang University Huzhou Research Institute, officially announcing the completion of its first-round financing in the amount of several tens of millions of RMB. This round of financing was jointly invested by Chuzhou Lion City HONSUN Venture Capital Investment Partnership and Jiangsu HONSUN Medical Electronic Co., Ltd., with the aim of accelerating the industrialization of AIMED's remote cardiopulmonary sound AI preliminary screening and quality control system, and promoting the adoption of smart healthcare solutions for the benefit of the public.
Founded in 2025, AIMED is a technology company incubated by the Zhejiang University Huzhou Research Institute, focusing on the industrial application of medical artificial intelligence. The company is dedicated to addressing the clinical challenge of early screening for cardiopulmonary diseases through AI technology, and has launched the first clinically stable AI-assisted auscultation system in China.
The system leverages the only electronic stethoscope in China that has obtained triple medical device certifications from the FDA 510K, CE, and NMPA, combined with a cardiopulmonary disease identification model trained on over 100,000 high-quality clinical cardiopulmonary sound samples. It is capable of accurately identifying a wide range of cardiopulmonary conditions, including structural heart disease, congenital heart disease, pneumonia, and chronic obstructive pulmonary disease (COPD). Within less than six months of launch, the system has already provided assisted diagnosis and early screening services for tens of thousands of patients across more than 30 medical institutions nationwide.
As AIMED's strategic partner, HONSUN has a business footprint covering blood pressure monitoring, respiratory therapy, home care, and departmental diagnostics. With years of deep cultivation in the mechanical sphygmomanometer and stethoscope niche markets, the company possesses a vast customer base and significant product advantages. HONSUN has built a complete industrial chain spanning product R&D, intelligent manufacturing, and global sales. Its products have obtained multiple international certifications, including EU CE and U.S. FDA, and the company holds extensive experience in medical device compliance and a strong portfolio of proprietary technologies. HONSUN's products are exported to over 110 countries and regions worldwide.
Contact Information
Tel: +86 513 80580098
Fax: +86 513 80580098
E-mail: aileen-yan@lordmed.com
Address: No.8 Tongxing Road, Economic & Technological Development Area, 226009, Nantong City, China